Sphera Funds Management »

Lam Research shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Lam Research (LRCX) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Lam Research

Tip: Access up to 7 years of quarterly data

All positions including Lam Research held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lam Research by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.0M 19k 433.33

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Biogen Idec (BIIB)
Mineralys Therapeutics (MLYS)
Tower Semiconductor Shs New (TSEM)
Cytokinetics Com New (CYTK)
Spdr Series Trust St Str Sp Biot Put Option (XBI)
Syndax Pharmaceuticals (SNDX)
Ultragenyx Pharmaceutical (RARE)
BioMarin Pharmaceutical (BMRN)
Bridgebio Pharma (BBIO)
Cogent Biosciences (COGT)
NOVA MEASURING Instruments L (NVMI)
Insmed Com Par $.01 (INSM)
Maze Therapeatics (MAZE)
Astrazeneca Ord (AZN)

View all positions for Sphera Funds Management

Top funds holding Lam Research

BlackRock
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Geode Capital Management
FMR
Morgan Stanley
Norges Bank Investment Management
Ameriprise Financial
Susquehanna International
Northern Trust
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding Lam Research